Classification and specific primer design for accurate detection of SARS-CoV-2 using deep learning.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
13 01 2021
Historique:
received: 05 10 2020
accepted: 21 12 2020
entrez: 14 1 2021
pubmed: 15 1 2021
medline: 23 1 2021
Statut: epublish

Résumé

In this paper, deep learning is coupled with explainable artificial intelligence techniques for the discovery of representative genomic sequences in SARS-CoV-2. A convolutional neural network classifier is first trained on 553 sequences from the National Genomics Data Center repository, separating the genome of different virus strains from the Coronavirus family with 98.73% accuracy. The network's behavior is then analyzed, to discover sequences used by the model to identify SARS-CoV-2, ultimately uncovering sequences exclusive to it. The discovered sequences are validated on samples from the National Center for Biotechnology Information and Global Initiative on Sharing All Influenza Data repositories, and are proven to be able to separate SARS-CoV-2 from different virus strains with near-perfect accuracy. Next, one of the sequences is selected to generate a primer set, and tested against other state-of-the-art primer sets, obtaining competitive results. Finally, the primer is synthesized and tested on patient samples (n = 6 previously tested positive), delivering a sensitivity similar to routine diagnostic methods, and 100% specificity. The proposed methodology has a substantial added value over existing methods, as it is able to both automatically identify promising primer sets for a virus from a limited amount of data, and deliver effective results in a minimal amount of time. Considering the possibility of future pandemics, these characteristics are invaluable to promptly create specific detection methods for diagnostics.

Identifiants

pubmed: 33441822
doi: 10.1038/s41598-020-80363-5
pii: 10.1038/s41598-020-80363-5
pmc: PMC7806918
doi:

Substances chimiques

DNA Primers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

947

Références

Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Mayo Clin Proc. 2020 Aug;95(8):1701-1703
pubmed: 32753142
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Mol Biol Evol. 2020 Sep 1;37(9):2699-2705
pubmed: 32289821
Science. 2018 Oct 26;362(6413):404-406
pubmed: 30361362
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Viruses. 2018 Sep 21;10(10):
pubmed: 30241410
BMC Bioinformatics. 2019 Sep 18;20(1):480
pubmed: 31533612
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
J Med Virol. 2020 Jun;92(6):538-539
pubmed: 32096564
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635415
Cell Death Discov. 2019 Jun 5;5:101
pubmed: 31231549
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Virology. 2012 Oct 25;432(2):427-34
pubmed: 22819835
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
J Clin Virol. 2018 Apr;101:52-56
pubmed: 29427907
Brief Bioinform. 2014 May;15(3):419-30
pubmed: 24197932
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Viruses. 2020 Nov 19;12(11):
pubmed: 33228210
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W71-4
pubmed: 17485472
Bioinformatics. 2003 Mar 1;19(4):513-23
pubmed: 12611807
J Korean Med Sci. 2020 Feb 10;35(5):e61
pubmed: 32030925
N Engl J Med. 2020 Aug 6;383(6):e38
pubmed: 32502334
Viruses. 2010 Aug;2(8):1804-1820
pubmed: 21994708
BMC Genomics. 2013 Jul 04;14:444
pubmed: 23822119
Eur Radiol. 2021 Aug;31(8):6096-6104
pubmed: 33629156
PLoS One. 2020 Apr 24;15(4):e0232391
pubmed: 32330208
Quant Biol. 2020 Mar;8(1):64-77
pubmed: 34084563
Methods Enzymol. 1990;183:63-98
pubmed: 2156132
Bull World Health Organ. 2005 Sep;83(9):707-10
pubmed: 16211163
J Gen Virol. 2007 Nov;88(Pt 11):3067-3077
pubmed: 17947532
PLoS One. 2020 Dec 10;15(12):e0242958
pubmed: 33301459
PLoS One. 2018 May 2;13(5):e0195885
pubmed: 29718947
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
PLoS One. 2019 Sep 11;14(9):e0222271
pubmed: 31509583
Cell Mol Immunol. 2020 Aug;17(8):881-883
pubmed: 32555321
Cell. 2020 Apr 16;181(2):223-227
pubmed: 32220310
FEBS Lett. 2006 Dec 22;580(30):6807-12
pubmed: 17141229

Auteurs

Alejandro Lopez-Rincon (A)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands. a.lopezrincon@uu.nl.

Alberto Tonda (A)

UMR 518 MIA-Paris, INRAE, c/o 113 rue Nationale, 75103, Paris, France.

Lucero Mendoza-Maldonado (L)

Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Salvador Quevedo y Zubieta 750, Independencia Oriente, C.P. 44340, Guadalajara, Jalisco, México.

Daphne G J C Mulders (DGJC)

Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.

Richard Molenkamp (R)

Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.

Carmina A Perez-Romero (CA)

Departamento de Investigación, Universidad Central de Queretaro (UNICEQ), Av. 5 de Febrero 1602, San Pablo, 76130, Santiago de Querétaro, QRO, Mexico.

Eric Claassen (E)

Athena Institute, Vrije Universiteit, De Boelelaan 1085, 1081 HV, Amsterdam, The Netherlands.

Johan Garssen (J)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands.
Department Immunology, Danone Nutricia research, Uppsalalaan 12, 3584 CT, Utrecht, The Netherlands.

Aletta D Kraneveld (AD)

Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, The Netherlands.

Articles similaires

Databases, Protein Protein Domains Protein Folding Proteins Deep Learning
Humans Multiple Myeloma Male Aged Glomerulosclerosis, Focal Segmental

Total elbow arthroplasty in England.

Zaid Hamoodi, Adrian Sayers, Michael R Whitehouse et al.
1.00
Humans England Female Male Arthroplasty, Replacement, Elbow
Humans COVID-19 Immunoglobulin G Antibodies, Viral SARS-CoV-2

Classifications MeSH